logo

For the Inventor, By the Inventor

Southborough, MA, United States of America

William Markland

This inventor holds 27 USPTO granted patents and 4 EPO patents, primarily in Kunitz Domain Proteins. Top assignees: Dyax Corporation, Vertex Pharmaceuticals, Inc., Protein Engineering Corporation. Active years: 1993-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Markland. Retrieved from https://idiyas.com/inventor/william-markland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27

% Patents Active = 55.6

 

Average Co-Inventor Count = 3.2

ph-index = 20

Forward Citations = 5,209(Granted Patents)


Location History:

  • Milford, MA (US) (1993 - 2011)
  • Southborough, MA (US) (2008 - 2014)
  • Boston, MA (US) (2021 - 2024)

Company Filing History:

goldMedal20 out of 174 
 
Dyax Corporation
 patents
silverMedal4 out of 1,167 
 
Vertex Pharmaceuticals, Inc.
 patents
bronzeMedal3 out of 5 
 
Protein Engineering Corporation
 patents

Years Active: 1993-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Kunitz Domain
Cancer Treatment
DNA-PK Inhibitors
JNK Kinases
Binding Proteins
Nucleic Acids
Plasmin Inhibitors
Directed Evolution
Protein Engineering
Chimeric Proteins
Crystallization
Peptide Library
27 patents (USPTO):Explore Patents
1. 11980633 - Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors (2024-05-14),
2. 11110108 - Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors (2021-09-07),
3. 8663629 - Kallikrein-binding 'kunitz domain' proteins and analogues thereof (2014-03-04),
4. 8431359 - Nucleic acids encoding polypeptide inhibitors of human plasmin derived from the Kunitz domains (2013-04-30),
5. 8283321 - Kallikrein-binding 'Kunitz domain' proteins and analogues thereof (2012-10-09),
6. 8002891 - Crystallization of C-Jun N-Terminal Kinase 3 (JNK3) (2011-08-23),
7. 7919462 - Inhibitors of human plasmin derived from the Kunitz domains (2011-04-05),
8. 7893007 - Directed evolution of novel binding proteins (2011-02-22),
9. 7628983 - Kallikrein-binding 'Kunitz domain' proteins and analogues thereof (2009-12-08),
10. 7413537 - Directed evolution of disulfide-bonded micro-proteins (2008-08-19),
11. 7383135 - Methods of designing inhibitors for JNK kinases (2008-06-03),
12. 7208293 - Directed evolution of novel binding proteins (2007-04-24),
13. 7118879 - Method of recovering a nucleic acid encoding a proteinaceous binding domain which binds a target material (2006-10-10),
14. 7078383 - ITI-D1 Kunitz domain mutants as HNE inhibitors (2006-07-18),
15. 6979538 - Directed evolution of novel binding proteins (2005-12-27),

Title: The Innovative Journey of William Markland

Introduction: William Markland, a distinguished inventor hailing from Southborough, MA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Markland's latest patents include a cutting-edge software application for enhancing cybersecurity measures in financial institutions and a revolutionary medical device aimed at improving patient care in hospitals.

Career Highlights: With over two decades of experience in the tech industry, Markland has a proven track record of developing innovative solutions that have garnered international acclaim. His expertise lies in merging technology with real-world applications to address pressing societal needs.

Collaborations: Throughout his career, Markland has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: William Markland's relentless pursuit of innovation and his passion for creating technology-driven solutions have solidified his position as a trailblazer in the world of inventors. His work continues to inspire future generations to push the boundaries of what is possible in the realm of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…